Harvard Bioscience, Inc. (NASDAQ:HBIO)
| CAPS Rating |
|
|---|---|
| Open | $4.12 |
| Previous Close | $4.18 |
| Daily Range | $4.10 - $4.19 |
| 52-Week Range | $3.80 - $6.26 |
| Market Cap | $117.66M |
| P/E Ratio | 7.50 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 40,396 |
| Average Daily Volume | 0 |
HBIO
VS S&P 500 (SPY)
How do you think HBIO will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
HBIO Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
HBIO News and Commentary
- Stem Cell Therapy May Prevent Heart Failure: 4 Companies to Watch – NASDAQ
- Insider Buying Alert: 9 Stocks That Everyone Thinks Will Soar Higher – The Motley Fool
- Here's How Harvard Bioscience May Be Failing You – The Motley Fool
- 5 Likely Additions to the Russell 2000 – SeekingAlpha
- 5-Star Stocks Poised to Pop: Harvard Bioscience – The Motley Fool
- 4 Stock Ideas as Bulls Keep Their Horns Sharp – SeekingAlpha
- Tomorrow's Monster Stock? – The Motley Fool
- 4 Cash-Rich Small Cap Stocks With Significant Insider Buying – SeekingAlpha
- Is Toll Brothers a Good Turnaround Play? – The Motley Fool
- Where Is PerkinElmer's Bottom Line Headed? – The Motley Fool
- Today's 5-Star Movers – The Motley Fool
- A Setback at Invitrogen: Fool by Numbers – The Motley Fool
- FEI to the Sky: Fool by Numbers – The Motley Fool
- Biotech Goes to Harvard – The Motley Fool
Related News and Articles
- Illuminating the Way Forward for Genomics – The Motley Fool
- Life Technologies' Sequence of Success – The Motley Fool
- Has Sequenom Become the Perfect Stock? – The Motley Fool
- Hang Tight: This Bid Will Increase – The Motley Fool
RSS Headlines
Fool UK
